Issue 4, 2013

Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication

Abstract

Human p300/CBP associated factor bromodomain (PCAF BRD), a relatively conserved host cell protein, can selectively bind with Tat-AcK50 (tat acetylated lys50). This interaction is essential for the transcription activation of HIV-1 viral gene, therefore PCAF BRD provides a potential targeting protein to inhibit the transcription. We synthesized a series of N1-aryl-propane-1,3-diamine compounds to bind to PCAF BRD. And cellular level anti-HIV-1 assay showed that these small molecules had good inhibitory potency on HIV-1 replication, which was consistent with the molecular assay. Also, it was found that 3-(2-nitrophenoxy) propan-1-amine derivatives had strong bioactivity against HIV-1 replication.

Graphical abstract: Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication

Supplementary files

Article information

Article type
Concise Article
Submitted
20 Sep 2012
Accepted
26 Feb 2013
First published
28 Feb 2013

Med. Chem. Commun., 2013,4, 737-740

Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication

Q. Wang, R. Wang, B. Zhang, S. Zhang, Y. Zheng and Z. Wang, Med. Chem. Commun., 2013, 4, 737 DOI: 10.1039/C3MD20376J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements